What is the epigenome and how is it altered by lifestyle habits

AI-generated summary

The epigenome comprises chemical tags on DNA and its packaging proteins that regulate which genes are used, when, and to what extent. These marks do not change the DNA sequence but alter how genes are read, linking heredity with environment, age, and lifestyle. Major mechanisms include DNA methylation, histone modifications, and regulatory RNAs, which change DNA accessibility and adjust gene activity in a graded, probabilistic way rather than a simple on/off switch. Epigenetic patterns vary by cell type and over time, explaining why identical genomes—such as in monozygotic twins—can produce different health outcomes as life experiences diverge.

Lifestyle factors like diet, exercise, sleep, and stress influence epigenetic marks in tissue-specific ways, contributing to metabolic, inflammatory, and ageing-related processes. Epigenetic clocks estimate biological age from methylation patterns but their interpretation and clinical utility remain limited. In medicine, epigenomics enriches precision approaches by providing dynamic biomarkers that reflect both inherited biology and cumulative exposures. Ambitious efforts such as cell reprogramming aim to restore youthful function by resetting epigenetic states; partial reprogramming shows promise but raises safety and efficacy questions. Overall, epigenetics reframes genetic influence as an ongoing dialogue with the environment, offering paths for prevention and treatment while underscoring realistic limits to control.

The epigenome regulates which genes are activated in each cell and can change with age, environment, and lifestyle habits. Understanding it opens up new avenues for prevention, precision medicine, and longevity research.

The epigenome is the set of chemical modifications that are placed on the DNA and the proteins that organize it, regulating which genes each cell can use, at what time and with what intensity. These marks keep the DNA sequence intact, but influence its reading, so they help explain how environment, age and lifestyle habits are related to gene expression.

The most useful comparison is to imagine DNA as a great instruction book and the epigenome as the signaling system that indicates which chapters should remain accessible. A neuron, a muscle cell and a liver cell contain practically the same genetic sequence, although each one consults different instructions to fulfill its function. The US National Human Genome Research Institute (NHGR) defines the epigenome as the set of chemical modifications of DNA and associated proteins that alter gene expression, and recalls that these marks vary between cell types and can change during development, aging, disease or exposure to the environment.

This ability to adapt makes the epigenome a bridge between heredity and experience, although its functioning is more like a gradual adjustment of probabilities than a switch capable of activating a specific gene at will.

What is the epigenome and how does it regulate your genes?

The genome brings together the DNA sequence inherited from our parents and remains relatively stable throughout life, while the epigenome organizes the use of this information and responds more plastically to the needs of each cell. Its main mechanisms include DNA methylation, modifications of histones – the proteins around which DNA is coiled – and different regulatory RNAs.

These layers modify the accessibility of DNA. When a region is more compacted, it is more difficult for the cellular machinery to read it; when it is kept open, certain genes can be expressed more easily. Regulation is much more complex than a division between on and off genes, because thousands of coordinated signals are involved.

How DNA methylation works

Methylation adds small chemical groups, called methyl groups, to specific locations in DNA. An important part of the process occurs in regions known as CpG sites and, depending on their location, can reduce, modulate, or stabilize the activity of a gene. It is also involved in embryonic development, cell differentiation, and the maintenance of tissue identity. These tags can alter gene expression and be conserved when cells divide.

Diet, physical activity, stress, circadian rhythms, and other exposures can be associated with changes in these patterns, although detecting a mark next to a behavior or disease lacks sufficient value to prove that it is the cause. Sometimes it acts as a consequence and often reflects processes that are still being investigated.

Why Two Identical Twins Develop Different Diseases

Monozygotic twins share virtually the same DNA sequence, but their biological trajectories separate as they accumulate different experiences, exposures, and habits. A study led by Manel Esteller and Mario Fraga found that epigenetic differences were smaller in young twins and increased in older couples, especially when they had spent less time together or maintained more different lifestyles. These variations affected methylation, histones, and gene expression profiles.

The epigenome thus provides part of the explanation for why two people with an almost identical genetic basis may have different disease risks. Acquired mutations, infections, biological chance, social environment and access to care are also involved.

How lifestyle habits alter the epigenome

Epigenetics provides a biological framework for understanding how behavior repeated over years can leave measurable signals in cells, although the evidence depends on the tissue analyzed. Blood, muscle, brain, or liver may respond differently, so an accessible sample does not always represent what is happening throughout the body.

Diet, stress, sleep and exercise as epigenetic modifiers

Diet influences metabolism and provides molecules that participate in methylation reactions, as well as modulating inflammation, energy balance and the microbiota. This has boosted nutrigenomics and personalized nutrition, although science is still far from assigning each food a universal epigenetic effect. Dietary patterns and metabolic status matter more than the search for an ingredient capable of “rejuvenating” DNA.

Exercise produces epigenetic adaptations in skeletal muscle and other tissues linked to metabolism and inflammatory response. Different studies have described changes in methylation and histones after physical activity programs, although their magnitude varies according to the type of exercise, intensity, duration and characteristics of each person.

Sleep is closely related to circadian rhythms, which coordinate the expression of genes during the day and night. Lack of rest, irregular schedules and some sleep-disordered breathing have been associated with epigenetic alterations and an acceleration of certain biological clocks, but there is still a lack of studies that allow individualized recommendations to be made.

Sustained stress can also influence through hormones, inflammation, and behavioral changes. A study by Jesse Poganik and other researchers, published in Cell Metabolism in 2023, found that several acute physiological stress situations—such as emergency surgery, pregnancy, or severe COVID-19—were associated with transient increases in biological age estimated by different epigenetic clocks. After recovery, those estimates tended to descend toward their previous values. The result suggests plasticity, although biological clocks measure different dimensions and still need a more precise interpretation.

Activate longevity genes or awaken predispositions to chronic diseases

The expression “activate longevity genes” works as an informative metaphor, but simplifies a reality made up of genetic networks, metabolism, immune system, cell repair and environment. A healthy habit can favor biological profiles associated with lower risk, while harmful exposure can reinforce processes related to inflammation, insulin resistance or cell damage. None of these effects guarantee an individual result.

Epigenetic clocks analyze methylation patterns to estimate biological age or the rate of aging. Some are associated with mortality, chronic disease, and functional loss, although different clocks may offer different results and their meaning remains open. Therefore, commercial tests should be interpreted with caution and never substitute for a clinical assessment.

The practical application is less spectacular and more useful: a balanced diet, regular physical activity, sufficient sleep and proper stress management maintain well-established health benefits, and some of these may be mediated by epigenetic mechanisms. Epigenetics adds a molecular explanation, but habits continue to modify risks instead of offering exact control over genes.

The epigenome and the transformation of medicine: from reactive to predictive

Precision medicine combines genetic, epigenetic, clinical, environmental, and behavioral information to better classify patients, anticipate risks, and select interventions tailored to each profile. The epigenome adds a valuable dimension because it reflects both inherited biology and the cumulative history of exposures, and can provide dynamic biomarkers for tracking a disease or response to treatment.

Precision Medicine and Personalized Nutrition

In oncology, neurology, metabolic diseases and ageing, researchers are studying epigenetic signatures that can improve diagnosis, identify patient subtypes or reveal new therapeutic targets. In personalised nutrition, the aim is to combine molecular data with habits, microbiota and metabolic response, although their clinical usefulness will need to be demonstrated with robust assays and reproducible results.

This transition connects with the conversation between the Bankinter Innovation Foundation and Francis Collins, a key figure in the Human Genome Project, on the move from reading DNA to interpreting and modifying it with tools such as CRISPR and artificial intelligence. Understanding which genes are activated in each tissue is one of the great biomedical frontiers, because all cells share the same instruction book and run very different programs.

The longevity market, biotechnology and digital health

The advancement of epigenomics opens up business opportunities in molecular diagnostics, drug discovery, prevention, personalized nutrition, digital monitoring and longevity services. It also raises the bar for demand, since a commercial proposal needs to demonstrate analytical validity, clinical utility, data protection and the absence of bias between populations.

The ability to identify risks before symptoms appear could direct resources towards prevention and reduce some of the burden associated with chronic diseases, provided that the tools are reliable and accessible. The economic value will depend less on selling a “biological age” figure and more on turning data into useful medical decisions.

This evolution is part of a broader scientific transformation: the possibility of studying cells as systems on which we can intervene, design new biological functions and develop increasingly precise therapies. The Bankinter Innovation Foundation’s report on synthetic biology analyses this convergence between genetics, artificial intelligence, automation and biological design, as well as the challenges posed by transferring these capabilities from the laboratory to clinical practice.

Altos Labs and epigenetic reprogramming

Altos Labs represents one of the most ambitious projects in this ecosystem. The company was launched in 2022 with initial funding of 3,000 million dollars and a mission focused on restoring cellular health and resilience through rejuvenation programmes, with the aim of acting on diseases, injuries and disabilities related to tissue deterioration.

His work brings together academic research, biotechnology, computing and drug development, with scientists such as Juan Carlos Izpisua Belmonte, Rick Klausner and Wolf Reik among its research leaders. The approach is based on a powerful question: can a cell regain some of its youthful functioning without losing its identity?

What is cell reprogramming

The scientific basis for cell reprogramming dates back to the work of Shinya Yamanaka, who demonstrated in 2006 that a specialized adult cell could return to a pluripotent state using a small set of transcription factors. The finding changed the understanding of cell identity and earned him, along with John Gurdon, the Nobel Prize in Physiology or Medicine in 2012.

This discovery gave rise to induced pluripotent stem cells or iPS cells, adult cells reprogrammed to regain the ability to become almost any cell type. iPS cells make it possible to study diseases, test drugs and develop new approaches in regenerative medicine without the need to use embryos.

Complete reprogramming erases much of a cell’s epigenetic identity and returns it to a state similar to that of a stem cell. Partial reprogramming seeks to stop the process before it reaches that point, with the intention of recovering functions associated with a younger cell while retaining its specialization. That balance is critical, because excessive reprogramming can alter tissue identity and increase biological risks.

Resetting epigenetic marks to rejuvenate cells

Talk of “resetting marks” helps visualize the goal, although Altos Labs and other groups are working on entire cellular systems, where gene expression, chromatin, metabolism, and damage repair are involved. The company itself links its scientific origin to Yamanaka’s discovery and is studying how to separate rejuvenation from loss of cell identity.

Partial reprogramming experiments have shown promising results in cells and animal models, but translation into human treatments raises questions about safety, duration of effect, delivery to specific tissues, and the relationship between epigenetic clocks and functional rejuvenation. Two papers published in 2024 in Nature Communications and Nature Aging report promising results from partial epigenetic reprogramming in human cells and animal models. They also warn that its mechanisms are not yet fully understood and that an estimated age reduction using epigenetic clocks does not, by itself, demonstrate functional cell rejuvenation.

The epigenome changes the way we understand the relationship between biology and habits because it shows that gene expression retains a degree of plasticity throughout life. This plasticity opens up opportunities to prevent, measure and treat better, although it maintains clear limits: habits modify risks and responses, research into reprogramming continues to advance and the promise of rejuvenating cells still belongs to the scientific field.

Between genetic determinism and promises of total control comes a more rigorous and also more potent idea: our genes matter, and how the organism uses them depends on an ongoing conversation with the environment.